Showing 1–10 of 10 results
-
-
| Open
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial
- C Le Tourneau
- , X Paoletti
- , N Servant
- , I Bièche
- , D Gentien
- , T Rio Frio
- , A Vincent-Salomon
- , V Servois
- , J Romejon
- , O Mariani
- , V Bernard
- , P Huppe
- , G Pierron
- , F Mulot
- , C Callens
- , J Wong
- , C Mauborgne
- , E Rouleau
- , C Reyes
- , E Henry
- , Q Leroy
- , P Gestraud
- , P La Rosa
- , L Escalup
- , E Mitry
- , O Trédan
- , J-P Delord
- , M Campone
- , A Goncalves
- , N Isambert
- , C Gavoille
- & M Kamal
British Journal of Cancer 111 , 17–24 -
Research |
-
| Open
-
-
| Open
-
Research |
-
-
| Open
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
- G Schleiermacher
- , J Michon
- , A Ribeiro
- , G Pierron
- , V Mosseri
- , H Rubie
- , C Munzer
- , J Bénard
- , N Auger
- , V Combaret
- , I Janoueix-Lerosey
- , A Pearson
- , D A Tweddle
- , N Bown
- , M Gerrard
- , K Wheeler
- , R Noguera
- , E Villamon
- , A Cañete
- , V Castel
- , B Marques
- , A de Lacerda
- , G P Tonini
- , K Mazzocco
- , R Defferrari
- , B de Bernardi
- , A di Cataldo
- , N van Roy
- , B Brichard
- , R Ladenstein
- , I Ambros
- , P Ambros
- , K Beiske
- , O Delattre
- & J Couturier
-
